Enanta Pharmaceuticals
ENTA
#7965
Rank
C$0.46 B
Marketcap
C$15.83
Share price
2.53%
Change (1 day)
54.11%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -C$0.11 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$65.32 Million. In 2024 the company made an earning of -C$0.14 Billion, an increase over its 2023 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.11 Billion-20.91%
2024 -C$0.14 Billion-23.87%
2023 -C$0.18 Billion4.39%
2022 -C$0.18 Billion-4.4%
2021 -C$0.18 Billion91.12%
2020 -C$93.2 Million-407.13%
2019 C$30.34 M-78.63%
2018 C$0.14 B117.97%
2017 C$65.15 M-574.65%
2016 -C$13.73 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$24.66 Million-137.98%
2012 C$64.89 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.24 B-34,342.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.01 B-20,904.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$9.20 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$7.06 B-6,771.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.34 B-17,435.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.38 B-12,749.60%๐Ÿ‡บ๐Ÿ‡ธ USA